Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock

10.1111/j.1476-5381.1996.tb15360.x

10.1023/A:1009870524359

10.1097/00003246-199507000-00021

10.1097/00003246-199707000-00001

10.1056/NEJM198411013111801

10.1097/00003246-199904000-00025

10.1097/00003246-199901001-00021

10.1097/00003246-199804000-00010

10.1001/jama.288.7.862

10.1007/BF02044113

10.1016/0140-6736(91)91641-7

10.1097/00000658-197707000-00005

10.1016/S0002-9343(99)80373-8

10.1097/00003246-199804000-00002

10.1001/jama.283.8.1038

10.1210/er.21.1.55

10.1097/00003246-199607000-00010

10.1097/00003246-199206000-00025

10.1001/jama.1993.03510240069035

10.1007/BF01709751

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.J R Stat Soc Ser B1995;57:289–300.

Briegel J, Forst H, Hellinger H, Haller M. Contribution of cortisol deficiency to septic shock.Lancet1991;338:507–508.

Schneider AJ, Voerman HJ. Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids.Intensive Care Med1991;17:436–437.

10.1007/BF00180547

10.1007/s001340000685

10.1046/j.1365-2125.1998.00833.x

10.1164/ajrccm.161.6.9812004

10.1034/j.1399-6576.1999.430307.x

Parker MM. Pathophysiology of cardiovascular dysfunction in septic shock.New Horiz1998;6:130–138.

Endo S, Inada K, Nakae H, Arakawa N, Takakuwa T, Yamada Y, Shimamura T, Suzuki T, Taniguchi S, Yoshida M. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.Res Commun Mol Pathol Pharmacol1996;91:347–356.

10.1007/BF01709336

10.1016/0167-0115(96)00080-8

10.1097/00003246-199801000-00032

10.1097/00003246-199901001-00021

10.1097/00024382-199704000-00001

10.1073/pnas.87.24.10043

10.1073/pnas.87.24.10043

10.1074/jbc.271.39.23928

10.1073/pnas.93.1.255

10.1074/jbc.272.26.16679

10.1042/cs0820597

10.1016/S0008-6363(98)00230-2

10.1097/00003246-199703000-00006

10.1007/BF01709331

10.1097/00003246-199404000-00025

10.1016/0002-9343(91)90069-A

10.1097/00000658-199204000-00009

10.1016/S0140-6736(94)92029-X

10.1097/00003246-199404000-00022

Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.J Inflamm1995;46:212–219.

10.1007/s001340051277

10.1378/chest.104.3.847

10.1182/blood.V93.8.2730

10.1161/01.CIR.96.1.295

10.1001/archsurg.1996.01430230023005

10.1681/ASN.V12suppl_1s70

10.1016/0167-5699(96)80606-2

10.1034/j.1399-0012.1999.130501.x

Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cellsin vitro.J Immunol1996;156:2406–2412.

10.1097/00003246-199901000-00028

Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.Proc Assoc Am Physicians1996;108:374–381.

10.4049/jimmunol.164.4.1768

10.1006/cyto.1998.0362

10.1016/S0167-5699(97)01111-0

10.1016/0020-1383(88)90042-3

10.1007/BF01743727

10.1097/00003246-200205000-00010

10.1097/00006676-200210000-00006

10.1001/archinte.1997.00440250031004